Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    November 2018
  1. AHMMED B, Khan MN, Nisar MA, Kampo S, et al
    Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-kappaB signaling pathway.
    Int J Oncol. 2018 Nov 28. doi: 10.3892/ijo.2018.4650.
    PubMed     Text format     Abstract available


  2. XU YH, Tu JR, Zhao TT, Xie SG, et al
    Overexpression of lncRNA EGFRAS1 is associated with a poor prognosis and promotes chemotherapy resistance in nonsmall cell lung cancer.
    Int J Oncol. 2018 Nov 9. doi: 10.3892/ijo.2018.4629.
    PubMed     Text format     Abstract available


  3. CHEN L, Zhou Y, Tang X, Yang C, et al
    EGFR mutation decreases FDG uptake in nonsmall cell lung cancer via the NOX4/ROS/GLUT1 axis.
    Int J Oncol. 2018 Nov 6. doi: 10.3892/ijo.2018.4626.
    PubMed     Text format     Abstract available


  4. ZHAO H, Chen G, Ye L, Yu H, et al
    DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.
    Int J Oncol. 2018 Nov 5. doi: 10.3892/ijo.2018.4624.
    PubMed     Text format     Abstract available


    October 2018
  5. HUANG FX, Chen HJ, Zheng FX, Gao ZY, et al
    LncRNA BLACAT1 is involved in chemoresistance of nonsmall cell lung cancer cells by regulating autophagy.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4614.
    PubMed     Text format     Abstract available


  6. JIANG F, Yu Q, Chu Y, Zhu X, et al
    MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.
    Int J Oncol. 2018 Oct 29. doi: 10.3892/ijo.2018.4610.
    PubMed     Text format     Abstract available


  7. ZHANG X, Zhang X, Liu X, Qi P, et al
    MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer.
    Int J Oncol. 2018 Oct 19. doi: 10.3892/ijo.2018.4599.
    PubMed     Text format     Abstract available


  8. SUDO H, Tsuji AB, Sugyo A, Okada M, et al
    Direct comparison of 2amino[311C]isobutyric acid and 2amino[11C]methylisobutyric acid uptake in eight lung cancer xenograft models.
    Int J Oncol. 2018 Oct 16. doi: 10.3892/ijo.2018.4596.
    PubMed     Text format     Abstract available


  9. ZHANG W, Liu K, Pei Y, Ma J, et al
    Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/Factin pathways.
    Int J Oncol. 2018 Oct 8. doi: 10.3892/ijo.2018.4586.
    PubMed     Text format     Abstract available


    August 2018
  10. YOU C, Zhang S, Sun Y, Zhang S, et al
    beta-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors.
    Int J Oncol. 2018 Aug 21. doi: 10.3892/ijo.2018.4529.
    PubMed     Text format     Abstract available


  11. LI W, Shi Y, Wang R, Pan L, et al
    Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis.
    Int J Oncol. 2018 Aug 21. doi: 10.3892/ijo.2018.4533.
    PubMed     Text format     Abstract available


  12. CHIU YH, Hsu SH, Hsu HW, Huang KC, et al
    Human nonsmall cell lung cancer cells can be sensitized to camptothecin by modulating autophagy.
    Int J Oncol. 2018 Aug 14. doi: 10.3892/ijo.2018.4523.
    PubMed     Text format     Abstract available


  13. ABRAHAM V, Cao G, Parambath A, Lawal F, et al
    Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.
    Int J Oncol. 2018;53:488-502.
    PubMed     Text format     Abstract available


    July 2018
  14. TANG Q, Li M, Chen L, Bi F, et al
    miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Int J Oncol. 2018 Jul 20. doi: 10.3892/ijo.2018.4493.
    PubMed     Text format     Abstract available


  15. ZHOU J, Sun J, Chen H, Peng Q, et al
    Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
    Int J Oncol. 2018 Jul 6. doi: 10.3892/ijo.2018.4474.
    PubMed     Text format     Abstract available


  16. SHEN W, Pang H, Xin B, Duan L, et al
    Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2018 Jul 4. doi: 10.3892/ijo.2018.4469.
    PubMed     Text format     Abstract available


  17. FAN X, Liang Y, Liu Y, Bai Y, et al
    The upregulation of TMPRSS4, partly ascribed to the downregulation of miR125a5p, promotes the growth of human lung adenocarcinoma via the NFkappaB signaling pathway.
    Int J Oncol. 2018;53:148-158.
    PubMed     Text format     Abstract available


  18. CHANG CC, Liu TY, Lee YT, Chen YC, et al
    Genome-wide analysis of lncRNAs in 3'-untranslated regions: CR933609 acts as a decoy to protect the INO80D gene.
    Int J Oncol. 2018;53:417-433.
    PubMed     Text format     Abstract available


  19. SUMI T, Hirai S, Yamaguchi M, Tanaka Y, et al
    Survivin knockdown induces senescence in TTF1-expressing, KRAS-mutant lung adenocarcinomas.
    Int J Oncol. 2018;53:33-46.
    PubMed     Text format     Abstract available


    June 2018
  20. LUO X, Ye S, Jiang Q, Gong Y, et al
    Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/beta-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Int J Oncol. 2018 Jun 15. doi: 10.3892/ijo.2018.4442.
    PubMed     Text format     Abstract available


  21. ZHAO YY, Wu Q, Wu ZB, Zhang JJ, et al
    Microwave hyperthermia promotes caspase3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in nonsmall cell lung cancer cells.
    Int J Oncol. 2018 Jun 13. doi: 10.3892/ijo.2018.4439.
    PubMed     Text format     Abstract available


    May 2018
  22. FUJIWARA-KURODA A, Kato T, Abiko T, Tsuchikawa T, et al
    Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4425.
    PubMed     Text format     Abstract available


  23. KANG MA, Kim W, Jo HR, Shin YJ, et al
    Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS032, on cervical cancer.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4424.
    PubMed     Text format     Abstract available


  24. LIU DH, An M, Bao BL, Ren F, et al
    Nicotine inhibits CD24 expression in Lewis lung carcinoma cells by upregulation of RAS expression.
    Int J Oncol. 2018 May 22. doi: 10.3892/ijo.2018.4415.
    PubMed     Text format     Abstract available


  25. ZHANG W, Cai X, Yu J, Lu X, et al
    Exosome-mediated transfer of lncRNA RP11838N2.4 promotes erlotinib resistance in non-small cell lung cancer.
    Int J Oncol. 2018 May 17. doi: 10.3892/ijo.2018.4412.
    PubMed     Text format     Abstract available


  26. SHEN M, Chen Y, Xu L, Zhu R, et al
    Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells.
    Int J Oncol. 2018 May 4. doi: 10.3892/ijo.2018.4394.
    PubMed     Text format     Abstract available


  27. LIU K, Chen H, You Q, Ye Q, et al
    miR145 inhibits human nonsmall-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
    Int J Oncol. 2018 May 3. doi: 10.3892/ijo.2018.4393.
    PubMed     Text format     Abstract available


    April 2018
  28. DIAZ-RODRIGUEZ E, Sanz E, Pandiella A
    Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4373.
    PubMed     Text format     Abstract available


  29. ZHANG Y, Li XJ, He RQ, Wang X, et al
    Upregulation of HOXA1 promotes tumorigenesis and development of nonsmall cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4372.
    PubMed     Text format     Abstract available


  30. LI YJ, Sun YX, Hao RM, Wu P, et al
    miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.
    Int J Oncol. 2018;52:1328-1338.
    PubMed     Text format     Abstract available


    March 2018
  31. ZHANG G, Xue P, Cui S, Yu T, et al
    Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4347.
    PubMed     Text format     Abstract available


  32. ASAKA S, Yoshizawa A, Saito K, Kobayashi Y, et al
    Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4334.
    PubMed     Text format     Abstract available


  33. ZHANG L, Lu J, Zhou H, Du Z, et al
    Silencing of aquaporin 5 inhibits the growth of A549 lung cancer cells in vitro and in vivo.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4326.
    PubMed     Text format     Abstract available


  34. MARUOKA T, Kitanaka A, Kubota Y, Yamaoka G, et al
    Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents.
    Int J Oncol. 2018 Mar 13. doi: 10.3892/ijo.2018.4314.
    PubMed     Text format     Abstract available


  35. YI L, Sun D, Han Q, Liu Z, et al
    Interferon regulatory factor 3 mediates Poly(I:C)-induced innate immune response and apoptosis in nonsmall cell lung cancer.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4300.
    PubMed     Text format     Abstract available


  36. KAMINSKA K, Czarnecka AM, Khan MI, Fendler W, et al
    Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis.
    Int J Oncol. 2018;52:768-786.
    PubMed     Text format     Abstract available


  37. SUETSUGU T, Koshizuka K, Seki N, Mizuno K, et al
    Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells.
    Int J Oncol. 2018;52:913-924.
    PubMed     Text format     Abstract available


    February 2018
  38. MAJ E, Filip-Psurska B, Milczarek M, Psurski M, et al
    Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Int J Oncol. 2018;52:337-366.
    PubMed     Text format     Abstract available


  39. FRILLE A, Leithner K, Olschewski A, Olschewski H, et al
    No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Int J Oncol. 2018;52:518-526.
    PubMed     Text format     Abstract available


  40. KIM J, Hong SW, Kim S, Kim D, et al
    Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes.
    Int J Oncol. 2018;52:613-620.
    PubMed     Text format     Abstract available


    January 2018
  41. ANISIEWICZ A, Pawlik A, Filip-Psurska B, Turlej E, et al
    Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.
    Int J Oncol. 2018;52:103-126.
    PubMed     Text format     Abstract available


    November 2017
  42. RONG B, Yang S
    Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review).
    Int J Oncol. 2017 Nov 29. doi: 10.3892/ijo.2017.4214.
    PubMed     Text format     Abstract available


  43. SHI J, Guo J, Li X
    Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
    Int J Oncol. 2017 Nov 10. doi: 10.3892/ijo.2017.4201.
    PubMed     Text format     Abstract available


    October 2017
  44. GENG F, Jiang Z, Song X, Zhou H, et al
    Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of nonsmall cell lung cancer via regulating GSK-3beta/beta-catenin signaling.
    Int J Oncol. 2017 Oct 12. doi: 10.3892/ijo.2017.4154.
    PubMed     Text format     Abstract available


    September 2017
  45. JUNG SY, Kho S, Song KH, Ahn J, et al
    Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner.
    Int J Oncol. 2017 Sep 29. doi: 10.3892/ijo.2017.4141.
    PubMed     Text format     Abstract available


  46. YOSHIDA R, Sasaki T, Minami Y, Hibino Y, et al
    Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer.
    Int J Oncol. 2017 Sep 28. doi: 10.3892/ijo.2017.4140.
    PubMed     Text format     Abstract available


    June 2017
  47. GU Z, Fang X, Li C, Chen C, et al
    Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4055.
    PubMed     Text format     Abstract available


  48. MAEDA M, Chen Y, Lee S, Kumagai-Takei N, et al
    Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
    Int J Oncol. 2017;50:2024-2032.
    PubMed     Text format     Abstract available


  49. LI Y, Miao L, Yu M, Shi M, et al
    alpha1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
    Int J Oncol. 2017;50:1955-1964.
    PubMed     Text format     Abstract available


    May 2017
  50. PANG L, Han S, Jiao Y, Jiang S, et al
    Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4014.
    PubMed     Text format     Abstract available


  51. LI X, Han J, Zhu H, Peng L, et al
    miR181b5p mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4007.
    PubMed     Text format     Abstract available


  52. LU C, Shan Z, Hong J, Yang L, et al
    MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3999.
    PubMed     Text format     Abstract available


  53. WANG C, Chen K, Liao S, Gu W, et al
    The flightless I protein interacts with RNA-binding proteins and is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3995.
    PubMed     Text format     Abstract available


  54. UJIIE H, Kato T, Lee D, Hu HP, et al
    Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
    Int J Oncol. 2017 May 5. doi: 10.3892/ijo.2017.3984.
    PubMed     Text format     Abstract available


    April 2017
  55. SHI B, Wang LF, Meng WS, Chen L, et al
    Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3970.
    PubMed     Text format     Abstract available


  56. LIU C, Lv D, Li M, Zhang X, et al
    Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3967.
    PubMed     Text format     Abstract available


  57. LU S, Dong Z
    Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3964.
    PubMed     Text format     Abstract available


    March 2017
  58. YAMAMOTO G, Kikuchi M, Kobayashi S, Arai Y, et al
    Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.
    Int J Oncol. 2017 Mar 27. doi: 10.3892/ijo.2017.3935.
    PubMed     Text format     Abstract available


  59. TAN Q, Zuo J, Qiu S, Yu Y, et al
    Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3925.
    PubMed     Text format     Abstract available


  60. MAWAS AS, Amatya VJ, Suzuki R, Kushitani K, et al
    PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.
    Int J Oncol. 2017;50:1029-1034.
    PubMed     Text format     Abstract available


  61. CREGAN S, Breslin M, Roche G, Wennstedt S, et al
    Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
    Int J Oncol. 2017;50:1044-1052.
    PubMed     Text format     Abstract available


    February 2017
  62. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    PubMed     Text format     Abstract available


  63. KANG H, Zhang J, Wang B, Liu M, et al
    Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
    Int J Oncol. 2017;50:545-554.
    PubMed     Text format     Abstract available


  64. CHEN L, Wang L, Yan J, Ma C, et al
    131I-labeled monoclonal antibody targeting neuropilin receptor type-2 for tumor SPECT imaging.
    Int J Oncol. 2017;50:649-659.
    PubMed     Text format     Abstract available


    January 2017
  65. LEE S, Matsuzaki H, Maeda M, Yamamoto S, et al
    Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers.
    Int J Oncol. 2017;50:66-74.
    PubMed     Text format     Abstract available


    December 2016
  66. IM M, Kim A, Ma JY
    Ethanol extract of baked Gardeniae Fructus exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells: Role of suppression of the NF-kappaB and HIF-1alpha pathways.
    Int J Oncol. 2016;49:2377-2386.
    PubMed     Text format     Abstract available


  67. KATO T, Lee D, Wu L, Patel P, et al
    SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma.
    Int J Oncol. 2016;49:2411-2420.
    PubMed     Text format     Abstract available


  68. HWANG SJ, Park HG, Park Y, Lee HJ, et al
    An alpha-quaternary chiral latam derivative, YH-304 as a novel broad-spectrum anticancer agent.
    Int J Oncol. 2016;49:2480-2486.
    PubMed     Text format     Abstract available


    November 2016
  69. KUMAMOTO T, Seki N, Mataki H, Mizuno K, et al
    Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Int J Oncol. 2016;49:1870-1880.
    PubMed     Text format     Abstract available


    October 2016
  70. ZHOU H, Li J, Zhang Z, Ye R, et al
    RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
    PubMed     Text format     Abstract available


  71. TANAKA T, Imamura T, Yoneda M, Irie A, et al
    Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-alpha-TNFR1-NF-kappaB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis.
    Int J Oncol. 2016;49:1377-84.
    PubMed     Text format     Abstract available


  72. NOGIMORI K, Hori T, Kawaguchi K, Fukui T, et al
    Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.
    Int J Oncol. 2016;49:1369-76.
    PubMed     Text format     Abstract available


  73. QIN S, Yang C, Zhang B, Li X, et al
    XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC.
    Int J Oncol. 2016;49:1289-96.
    PubMed     Text format     Abstract available


    September 2016
  74. KIM JS, Kang SJ, Jeong HY, Kim MW, et al
    Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy.
    Int J Oncol. 2016;49:1130-8.
    PubMed     Text format     Abstract available


  75. ZHONG N, Shi S, Wang H, Wu G, et al
    Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
    Int J Oncol. 2016;49:1028-38.
    PubMed     Text format     Abstract available


    August 2016
  76. ZENG Y, Zhu J, Shen D, Qin H, et al
    Repression of Smad4 by miR205 moderates TGF-beta-induced epithelial-mesenchymal transition in A549 cell lines.
    Int J Oncol. 2016;49:700-8.
    PubMed     Text format     Abstract available


    July 2016
  77. CHEN M, Guo Y, Zhao R, Wang X, et al
    Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells.
    Int J Oncol. 2016;49:316-24.
    PubMed     Text format     Abstract available


    June 2016
  78. WU D, Mou YP, Chen K, Cai JQ, et al
    Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3551.
    PubMed     Text format     Abstract available


    May 2016
  79. KWON YS, Lee KS, Chun SY, Jang TJ, et al
    Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: